Accretion Pharmaceuticals Limited (NSE:ACCPL)
India
· Delayed Price · Currency is INR 103.50
+4.90 (4.97%)
At close: Apr 29, 2026
Accretion Pharmaceuticals Market Cap
Accretion Pharmaceuticals has a market cap or net worth of 1.15 billion as of April 29, 2026.
Market Cap
1.15B
Enterprise Value
1.23B
Revenue
826.43M
Ranking
n/a
PE Ratio
10.54
Stock Price
103.50
Market Cap Chart
Since May 21, 2025, Accretion Pharmaceuticals's market cap has increased from 922.07M to 1.15B, an increase of 24.77%. That is a compound annual growth rate of 26.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 1.15B | 17.81% |
| Dec 31, 2025 | 976.54M | 5.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Concord Drugs | 1.10B |
| Denis Chem Lab | 1.10B |
| Bal Pharma | 1.21B |
| Pharmaids Pharmaceuticals | 1.09B |
| Bilcare | 1.44B |
| Mercury Laboratories | 899.52M |
| Lactose (India) | 1.50B |
| Coral Laboratories | 1.50B |